Alessandro Preti

1.3k total citations · 1 hit paper
10 papers, 721 citations indexed

About

Alessandro Preti is a scholar working on Clinical Biochemistry, Molecular Biology and Immunology. According to data from OpenAlex, Alessandro Preti has authored 10 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 5 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Alessandro Preti's work include Advanced Glycation End Products research (6 papers), S100 Proteins and Annexins (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Alessandro Preti is often cited by papers focused on Advanced Glycation End Products research (6 papers), S100 Proteins and Annexins (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Alessandro Preti collaborates with scholars based in Italy, United States and Sweden. Alessandro Preti's co-authors include Marco E. Bianchi, Francesco De Marchis, Maura Casalgrandi, Emilie Vénéreau, Jaron Liu, Mariagrazia Uguccioni, Luca Varani, Angela Cattaneo, Huan Yang and Angela Bachi and has published in prestigious journals such as The Journal of Experimental Medicine, Frontiers in Immunology and The Journal of General Physiology.

In The Last Decade

Alessandro Preti

9 papers receiving 718 citations

Hit Papers

Mutually exclusive redox forms of HMGB1 promote cell recr... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Preti Italy 6 380 323 227 76 67 10 721
Lorena Amadio Italy 12 254 0.7× 324 1.0× 358 1.6× 38 0.5× 57 0.9× 15 865
H. Wu China 15 81 0.2× 113 0.3× 337 1.5× 46 0.6× 30 0.4× 24 820
Anne Rübsam Germany 10 92 0.2× 81 0.3× 297 1.3× 98 1.3× 57 0.9× 36 888
Andrea Hodgkinson United Kingdom 15 144 0.4× 89 0.3× 264 1.2× 20 0.3× 28 0.4× 28 702
Péter Reismann Hungary 13 152 0.4× 124 0.4× 215 0.9× 25 0.3× 26 0.4× 44 654
Pengchao Du China 9 48 0.1× 140 0.4× 302 1.3× 53 0.7× 22 0.3× 18 537
Soo Youn Choi South Korea 18 34 0.1× 170 0.5× 431 1.9× 21 0.3× 86 1.3× 35 878
Hironori Tamei Japan 9 315 0.8× 32 0.1× 159 0.7× 20 0.3× 64 1.0× 12 654
Takaya Ishihara Japan 17 379 1.0× 71 0.2× 1.1k 5.0× 22 0.3× 34 0.5× 25 1.4k

Countries citing papers authored by Alessandro Preti

Since Specialization
Citations

This map shows the geographic impact of Alessandro Preti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Preti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Preti more than expected).

Fields of papers citing papers by Alessandro Preti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Preti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Preti. The network helps show where Alessandro Preti may publish in the future.

Co-authorship network of co-authors of Alessandro Preti

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Preti. A scholar is included among the top collaborators of Alessandro Preti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Preti. Alessandro Preti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Preti, Alessandro, et al.. (2025). A note on smooth rotund norms which are not midpoint locally uniformly rotund. Journal of Mathematical Analysis and Applications. 550(2). 129544–129544.
2.
Ferrara, Michele, Lorena Maria Ferreira, Giorgia Careccia, et al.. (2020). Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions. Frontiers in Immunology. 11. 1122–1122. 35 indexed citations
3.
Leo, Federica De, Giacomo Quilici, Mario Tirone, et al.. (2019). Diflunisal targets the HMGB 1/ CXCL 12 heterocomplex and blocks immune cell recruitment. EMBO Reports. 20(10). 36 indexed citations
4.
Yang, Haining, Laura Pellegrini, Andrea Napolitano, et al.. (2015). Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death and Disease. 6(6). e1786–e1786. 58 indexed citations
5.
Vénéreau, Emilie, Maura Casalgrandi, Milena Schiraldi, et al.. (2012). Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. The Journal of Experimental Medicine. 209(9). 1519–1528. 561 indexed citations breakdown →
6.
Vénéreau, Emilie, Maura Casalgrandi, Milena Schiraldi, et al.. (2012). Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. The Journal of General Physiology. 140(4). i6–i6. 4 indexed citations
7.
Vénéreau, Emilie, Maura Casalgrandi, Milena Schiraldi, et al.. (2012). Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. The Journal of General Physiology. 140(3). i3–i3. 8 indexed citations
8.
Civelli, Maurizio, Alessandro Preti, Valentina Cenacchi, et al.. (2007). Single and multiple ascending dose studies of a novel tissue‐selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women. British Journal of Clinical Pharmacology. 64(3). 304–316. 4 indexed citations
9.
Preti, Alessandro. (2001). CRF antagonists Dupont.. PubMed. 2(2). 274–9. 3 indexed citations
10.
Preti, Alessandro. (2000). BP-897 Bioprojet.. PubMed. 1(1). 110–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026